 least 50% of baseline. If high intensity statin therapy (with or without ezetimibe) is
tolerated, target levels < 1.4 mmol/L (55 mg/dL) are
recommended.
Grade

Certainty of evidence

Best Practice Statement

Recommendation 24
In a person with diabetes and symptomatic peripheral artery
disease:

treatment with single antiplatelet therapy should be
used,
treatment with clopidog